JB Chem & Pharma
Ticker >

JB Chem & Pharma share price

JB Chemicals & Pharmaceuticals Ltd.

NSE: JBCHEPHARM BSE: 506943 SECTOR: Pharmaceuticals & Drugs  95k   408   68

1948.00
-13.80 (-0.70%)
BSE: 01 Nov 07:01 PM

Price Summary

Today's High

₹ 1998

Today's Low

₹ 1936.55

52 Week High

₹ 2029

52 Week Low

₹ 1376.95

FinStar

Ownership Stable
Ownership strength is slightly missing the benchmark.
ValuationExpensive
The stock is at a premium valuation at this point.
EfficiencyExcellent
The company knows very well the utilization of its assets.
FinancialsVery Stable
The company possesses stable growth history and manageable debt.
*It is just an analytical rating of the company and not an investment advice.

Company Essentials

Market Cap

₹ 30255.25 Cr.

Enterprise Value

₹ 30533.35 Cr.

No. of Shares

15.53 Cr.

P/E

52.89

P/B

10.36

Face Value

₹ 1

Div. Yield

0.63 %

Book Value (TTM)

₹  187.98

CASH

₹ 63.7 Cr.

DEBT

₹ 341.8 Cr.

Promoter Holding

53.74 %

EPS (TTM)

₹  36.83

Sales Growth

14.37%

ROE

21.45 %

ROCE

25.13%

Profit Growth

39.72 %

Add Your Ratio

* Total debt includes long term borrowing, short term borrowing plus current maturities of long-term borrowing
* Ratios are based on latest Audited Financial Result.

Your Added Ratios

Please login to Add & View your own added ratios.

Login

Brands

These are the brands of JB Chemicals & Pharmaceuticals Ltd.

Doktor Mom Metrogyl Rantac Nicardia Molunamax

Price Chart 1d 1w 1m 3m 6m 1Yr 3Yr 5Yr

 

Volume Chart 1d 1w 1m 3m 6m 1Yr 3Yr 5Yr

* Prices are based on daily market changes.

PE Chart 1w 1m 3m 6m 1Yr 3Yr 5Yr

PB Chart 1w 1m 3m 6m 1Yr 3Yr 5Yr

* The chart is based on the standalone earnings of the company. * Negative values and values more than 1000x in PE chart is considered 0.

Peer Comparison

View Full Peer Comparison
* The Peers list includes companies operating in the same industry and having comparable market cap.

 Group Companies

Track the companies of Group.

Ratios

Sales Growth

1 Year14.37%
3 Year20.36%
5 Year17.05%

Profit Growth

1 Year39.72%
3 Year6.72%
5 Year24.44%

ROE%

1 Year21.45%
3 Year19.35%
5 Year20.77%

ROCE %

1 Year25.13%
3 Year23.73%
5 Year26.1%

Debt/Equity

0.1245

Price to Cash Flow

38.34

Interest Cover Ratio

19.2224

CFO/PAT (5 Yr. Avg.)

1.0814950679584

Shareholding Pattern

Promoter Pledging %

Date Promoter % Pledge %
Sep 2024 53.74 0.00
Jun 2024 53.77 0.00
Mar 2024 53.78 0.00
Dec 2023 53.83 0.00
Sep 2023 53.86 0.00
Investors List
* Figures given above are % of equity capital

 Strengths

  • The company has shown a good revenue growth of 20.3568909555233% for the Past 3 years.
  • The company has significantly decreased its debt by 185.1318 Cr.
  • Company has been maintaining healthy ROCE of 23.7287139850404% over the past 3 years.
  • Company has a healthy Interest coverage ratio of 19.2224.
  • The Company has been maintaining an effective average operating margins of 24.4416365644642% in the last 5 years.
  • The company has an efficient Cash Conversion Cycle of 15.5282 days.
  • The company has a good cash flow management; CFO/PAT stands at 1.0814950679584.
  • The company has a high promoter holding of 53.74%.

 Limitations

  • The company has shown a poor profit growth of 6.71681444667702% for the Past 3 years.
  • The company is trading at a high PE of 52.89.
  • The company is trading at a high EV/EBITDA of 32.1807.

Quarterly Result (All Figures in Cr.)

PARTICULARS Jun 2023 Sep 2023 Dec 2023 Mar 2024 Jun 2024
Net Sales 852.58 836.76 800.1 809.2 952.31
Total Expenditure 617.75 601.92 585.41 614.15 678.93
Operating Profit 234.83 234.84 214.69 195.05 273.38
Other Income 5.13 6.84 6.61 16.1 5.16
Interest 11.21 9.46 11.52 8.32 4.32
Depreciation 30.65 31.5 33.37 39.72 40.01
Exceptional Items 0 0 0 0 0
Profit Before Tax 198.1 200.72 176.41 163.11 234.21
Tax 53.53 55.7 48.49 37.26 60.98
Profit After Tax 144.57 145.02 127.92 125.85 173.23
Adjusted EPS (Rs) 9.34 9.36 8.25 8.11 11.16

Profit & Loss (All Figures in Cr. Adjusted EPS in Rs.)

PARTICULARS Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024
Net Sales 1640.74 1892 2189.88 2884.16 3298.64
Total Expenditure 1272.5 1339.66 1681.15 2219.47 2421.57
Operating Profit 368.24 552.33 508.72 664.69 877.08
Other Income 49.57 115.92 38.8 8.65 37.02
Interest 3.16 7.19 4.95 34.31 40.52
Depreciation 65.09 67.36 71.28 111.99 135.24
Exceptional Items -10 0 0 0 0
Profit Before Tax 339.56 593.71 471.29 527.04 738.34
Tax 71.42 146.62 110.29 138.15 194.98
Net Profit 268.14 447.08 361 388.89 543.36
Adjusted EPS (Rs.) 17.35 28.93 23.36 25.13 35.01

Balance Sheet (All Figures are in Crores.)

Particulars Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024
Equity and Liabilities
Share Capital 15.46 15.46 15.46 15.48 15.52
Total Reserves 1429.83 1791 2088.21 2427 2870.74
Borrowings 0 0 0 383.22 23.64
Other N/C liabilities 73.29 86.41 476.54 610.28 451.8
Current liabilities 493.55 645.74 418.54 579.28 1235.44
Total Liabilities 2012.13 2538.61 2998.75 4015.26 4597.14
Assets
Net Block 583.21 564.6 1203.67 1821.66 1925.42
Capital WIP 16.17 25.57 13.91 44.41 63.32
Intangible WIP 0 0 4.77 10.74 12.74
Investments 202.42 145.88 145.69 146.75 166.58
Loans & Advances 3.59 5.62 427.63 507.64 293.26
Other N/C Assets 0.36 0.82 1.04 14.51 6.03
Current Assets 1206.39 1796.12 1202.05 1469.56 2129.78
Total Assets 2012.13 2538.61 2998.75 4015.26 4597.14
* Other Non-current Liabilities include Net deferred Liabilities

Cash Flows (All Figures are in Crores.)

PARTICULARS Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024
Profit from operations 339.56 593.71 471.29 527.04 738.34
Adjustment 15.19 -56.41 97.05 202.82 187.26
Changes in Assets & Liabilities 4.35 -61.45 -294.12 -12.62 -8.64
Tax Paid -87.15 -140.41 -127.12 -88.59 -127.93
Operating Cash Flow 271.95 335.43 147.1 628.64 789.03
Investing Cash Flow 23.79 -230.64 4.18 -955.86 -412.47
Financing Cash Flow -305.48 -86.9 -137.85 343.41 -374.08
Net Cash Flow -9.75 17.9 13.42 16.2 2.49

Corporate Actions

Investors Details

PARTICULARS Sep 2023% Dec 2023% Mar 2024% Jun 2024% Sep 2024%
promoters 53.86 53.83 53.78 53.77 53.74
tau investment holdings p... 53.86 53.83 53.78 53.77 53.74
PARTICULARS Sep 2023% Dec 2023% Mar 2024% Jun 2024% Sep 2024%
investors 46.14 46.17 46.22 46.23 46.26
axis mutual fund trustee ... - 2.64 2.70 2.83 2.81
canara robeco mutual fund... - 1.40 1.18 1.12 1.26
government pension fund g... 1.60 1.59 1.59 1.59 1.59
invesco india contra fund... - 1.44 1.21 1.20 1.20
investor education and pr... - - 0.36 - 0.36
kotak emerging equity sch... - - - 1.53 1.64
nippon life india trustee... - 3.15 3.15 2.98 2.99
investor education and pr... 0.36 0.71 - 0.36 -
kotak mahindra life insur... 1.03 1.01 1.00 - -
franklin india smaller co... 1.07 1.02 - - -
axis mutual fund trustee ... 1.99 - - - -
canara robeco mutual fund... 1.55 - - - -
invesco india contra fund... 1.59 - - - -
nippon life india trustee... 3.35 - - - -

Annual Reports

Ratings & Research Reports

Company Presentations

Company News

J.B.Chemicals & Pharmaceuticals informs about trading window closure26 Sep 2024, 5:32PM J.B.Chemicals & Pharmaceuticals informs about analyst meet3 Sep 2024, 12:02PM J.B. Chemicals & Pharmaceuticals informs about disclosure29 Aug 2024, 11:12AM J.B. Chemicals & Pharmaceuticals informs about allotment of equity shares under ESOS27 Aug 2024, 10:44AM JB Chem & Pharma - Quaterly Results8 Aug 2024, 5:06PM JB Chem & Pharma - Quaterly Results8 Aug 2024, 5:06PM JB Chem & Pharma - Quaterly Results8 Aug 2024, 5:06PM J. B. Chemicals & Pharmaceuticals informs about newspaper advertisement3 Jul 2024, 5:25PM J.B. Chemicals & Pharmaceuticals informs about transcript of conference call24 May 2024, 2:21PM JB Chem & Pharma - Quaterly Results17 May 2024, 6:24PM JB Chem & Pharma - Quaterly Results17 May 2024, 6:24PM JB Chem & Pharma - Quaterly Results6 Feb 2024, 4:00PM JB Chem & Pharma - Quaterly Results6 Feb 2024, 4:00PM JB Chem & Pharma - Quaterly Results6 Feb 2024, 4:00PM JB Chemicals & Pharmaceuticals to execute trade mark license agreement with Novartis Innovative Therapies AG19 Dec 2023, 2:43PM J.B. Chemicals & Pharmaceuticals informs about allotment of equity shares under ESOS30 Nov 2023, 10:30AM J.B. Chemicals & Pharmaceuticals informs about transcript of conference call13 Nov 2023, 5:18PM JB Chem & Pharma - Quaterly Results7 Nov 2023, 3:29PM JB Chem & Pharma - Quaterly Results7 Nov 2023, 3:29PM JB Chem & Pharma - Quaterly Results7 Nov 2023, 3:29PM J.B.Chemicals & Pharmaceuticals informs about trading window closure27 Sep 2023, 5:23PM JB Chemicals & Pharmaceuticals gets USFDA’s nod for Doxepin Hydrochloride Capsules23 Aug 2023, 2:23PM JB Chemicals gets nod to set up wholly-owned step-down subsidiary in Philippines 9 Aug 2023, 5:20PM JB Chem & Pharma - Quaterly Results9 Aug 2023, 3:43PM JB Chem & Pharma - Quaterly Results9 Aug 2023, 3:43PM JB Chem & Pharma - Quaterly Results9 Aug 2023, 3:43PM JB Chemicals & Pharmaceuticals informs about details of loss of certificate22 Jul 2023, 12:47PM USFDA completes inspection of J.B. Chemicals & Pharmaceuticals’ manufacturing facility at Gujarat12 Jun 2023, 2:50PM JB Chemicals & Pharmaceuticals reports 3% rise in Q4 consolidated net profit25 May 2023, 2:08PM J.B. Chemicals & Pharmaceuticals informs about disclosure of related party transactions25 May 2023, 9:41AM JB Chem & Pharma - Quaterly Results24 May 2023, 4:29PM JB Chem & Pharma - Quaterly Results24 May 2023, 4:29PM JB Chem & Pharma - Quaterly Results24 May 2023, 4:29PM JB Chem & Pharma - Quaterly Results8 Feb 2023, 6:31PM JB Chem & Pharma - Quaterly Results8 Feb 2023, 6:31PM J.B. Chemicals & Pharmaceuticals informs about disclosure23 Dec 2022, 11:13AM JB Chemicals & Pharmaceuticals acquires Razel franchise from Glenmark 22 Dec 2022, 10:43AM J. B. Chemicals & Pharmaceuticals informs about allotment of equity shares20 Dec 2022, 4:32PM JB Chemicals & Pharmaceuticals enters into agreement to acquire Razel franchise15 Dec 2022, 9:23AM J. B. Chemicals & Pharmaceuticals informs about closure of trading window 9 Dec 2022, 9:45AM JB Chemicals & Pharmaceuticals gets USFDA’s nod for Venlafaxine Extended Release Tablets30 Nov 2022, 4:12PM J.B. Chemicals & Pharmaceuticals informs about transcript of conference call 18 Nov 2022, 3:35PM JB Chem & Pharma - Quaterly Results12 Nov 2022, 10:15AM JB Chem & Pharma - Quaterly Results12 Nov 2022, 10:15AM JB Chem & Pharma - Quaterly Results12 Nov 2022, 10:15AM J.B.Chemicals & Pharmaceuticals informs about loss of share certificate28 Sep 2022, 1:32PM JB Chemicals & Pharmaceuticals informs about loss of share certificate9 Aug 2022, 4:04PM JB Chem & Pharma - Quaterly Results4 Aug 2022, 7:05PM JB Chem & Pharma - Quaterly Results4 Aug 2022, 7:05PM JB Chem & Pharma - Quaterly Results4 Aug 2022, 7:05PM

JB Chem & Pharma Stock Price Analysis and Quick Research Report. Is JB Chem & Pharma an attractive stock to invest in?

The Indian healthcare sector is expected to reach US$ 372 billion by 2022, driven by rising incomes, greater health awareness, lifestyle diseases and increasing access to insurance. Healthcare has become one of India’s largest sectors - both in terms of revenue and employment.

Healthcare comprises hospitals, medical devices, clinical trials, outsourcing, telemedicine, medical tourism, health insurance, and medical equipment. The structure of the healthcare delivery system in India consists of three broad segments: Primary care, Secondary care, and Tertiary care.

  • Primary care is the first point of contact between the population and the healthcare service providers. For example, Sub-center (SC), Primary Health Centre (PHC) and Community Health Centre (CHC) which is more relevant to rural areas (PHC’s).
  • Secondary care providers inpatient as well as outpatient medical services and includes simple surgical procedures. For example, District level & Mid-sized hospitals.
  • Tertiary care is the third level of the healthcare delivery system in the country. These hospitals are specialized consultative healthcare infrastructure. For example, Single specialty and Multi-specialty hospitals.

While healthcare services are offered by the public as well as private sectors, in urban as well as rural areas, generally people prefer private hospitals over public hospitals for treatment of diseases, illness, and sickness. So, let’s look into JB Chem & Pharma and its performance over the period of time. JB Chem & Pharma stock price today is Rs 1949.1.

  • Operating cash flow ratio: It measures the adequacy of a company’s cash generated from operating activities to pay off short-term financial obligations. JB Chem & Pharma cash from the operating activity was Rs 789.0331 Cr.
     
  • Financial Strength: Health care organizations usually have high debt loads and low equity capital in their balance sheet. So, Debt to Equity ratio is important to analyze the company’s sustainability. JB Chem & Pharma has a Debt to Equity ratio of 0.1245 , which is a strong indication for the company.
     
  • EPS growth: Investors should ensure the EPS figure is growing faster than revenue numbers because it indicates company management is increasing the efficiency with which it runs the company. In JB Chem & Pharma , the EPS growth was 39.326 % which is good for the company.
     
  • Operating profit margin: It determines a company's potential earnings. It assesses how well-managed a company with respect to its basic overhead costs and other operating expenses, JB Chem & Pharma has OPM of 26.5890198019574 % which is a good sign for profitability.
     
  • ROE: JB Chem & Pharma have a healthy ROE of 21.4459 %. ROE is an important financial parameter for hospitals & health care companies because they expand and grow rapidly. Therefore, ROE measures how efficiently a shareholder's fund is used for generating profits.
     
  • Share Price: - The current share price of JB Chem & Pharma is Rs 1949.1. One can use valuation calculators of ticker to know if JB Chem & Pharma share price is undervalued or overvalued.
Last Updated on:
Brief about JB Chem & Pharma

JB Chemicals & Pharmaceuticals Ltd Financials: Check Share price, Balance Sheet, Annual report and Quarterly Results for company analysis 

 

Welcome to the stock analysis page for JB Chemicals & Pharmaceuticals Ltd, designed to provide in-depth analysis and insights for long-term stock investors. Explore various topics related to the company's performance and prospects to make informed investment decisions.

JB Chemicals & Pharmaceuticals Ltd Share Price 

Track and analyze the share price of JB Chemicals & Pharmaceuticals Ltd, a critical indicator for investors. Gain insights into the company's valuation and market sentiment using our pre-built screening tools.

JB Chemicals & Pharmaceuticals Ltd Balance Sheet 

Evaluate the financial stability and performance of JB Chemicals & Pharmaceuticals Ltd through its balance sheet analysis. Ticker offers valuable information, allowing you to understand the company's liquidity, solvency, and capital structure. Utilize our premium feature, BVPS Analysis, to calculate fair value based on the balance sheet.

JB Chemicals & Pharmaceuticals Ltd Annual Report 

Access the comprehensive annual report of JB Chemicals & Pharmaceuticals Ltd on Ticker. The annual report provides detailed information about the company's performance, strategic direction, and future plans. Download it from Ticker for a deeper understanding of the company's operations.

JB Chemicals & Pharmaceuticals Ltd Dividend 

Discover the dividend policy and track record of JB Chemicals & Pharmaceuticals Ltd, reflecting the company's commitment to rewarding shareholders. Our pre-built screening tools enable you to evaluate the company's dividend history and potential.

JB Chemicals & Pharmaceuticals Ltd Quarterly Results 

Stay updated on JB Chemicals & Pharmaceuticals Ltd quarterly performance through our detailed analysis. Our premium feature, Earnings Multiple Approach, helps assess the company's stock value based on its quarterly results.

JB Chemicals & Pharmaceuticals Ltd Stock Price 

Monitor the stock price of JB Chemicals & Pharmaceuticals Ltd to understand market sentiment and price movement. Our platform provides a comprehensive stock price chart for assessing historical performance and trends.

JB Chemicals & Pharmaceuticals Ltd Price Chart 

The price chart visually represents the historical performance of JB Chemicals & Pharmaceuticals Ltd stock. Analyze patterns, trends, and price levels to make well-informed investment decisions.

JB Chemicals & Pharmaceuticals Ltd News 

Stay up to date with the latest news articles about JB Chemicals & Pharmaceuticals Ltd through our dedicated news section. Timely information is crucial for investors, and Ticker ensures you are informed about the company's developments.

JB Chemicals & Pharmaceuticals Ltd Concall Transcripts 

Gain deeper insights into JB Chemicals & Pharmaceuticals Ltd's operations and plans by accessing transcripts of conference calls with analysts and investors. These transcripts provide valuable information about the company's strategies and future outlook.

JB Chemicals & Pharmaceuticals Ltd Investor Presentations 

View informative investor presentations of JB Chemicals & Pharmaceuticals Ltd, providing insights into the company's growth prospects and investment opportunities. Ticker offers access to these presentations, helping you understand the company's value proposition.

JB Chemicals & Pharmaceuticals Ltd Promoters & Shareholders 

Understand the ownership structure of JB Chemicals & Pharmaceuticals Ltd by learning about the key promoters and major shareholders. This information can help gauge ownership concentration and potential alignment of interests.

JB Chemicals & Pharmaceuticals Ltd ROCE

JB Chemicals & Pharmaceuticals Ltd's Return on Capital Employed (ROCE) is a key financial metric that evaluates the company's profitability and efficiency in utilizing its capital investments. Our stock analysis page provides the ROCE data for JB Chemicals & Pharmaceuticals Ltd, enabling investors to assess the company's ability to generate returns on the capital employed. By analyzing this ratio, investors can gain insights into the company's financial performance and make informed investment decisions. Access the detailed ROCE information for JB Chemicals & Pharmaceuticals Ltd in the financials table or ratio section on this page.

JB Chemicals & Pharmaceuticals Ltd EBITDA

JB Chemicals & Pharmaceuticals Ltd's Earnings Before Interest, Taxes, Depreciation, and Amortization (EBITDA) is a crucial measure for evaluating the company's operational performance and profitability. By analyzing the company's core earnings, investors can gain valuable insights into its financial health. Our stock analysis page offers comprehensive EBITDA data for JB Chemicals & Pharmaceuticals Ltd, enabling investors to assess the company's operational efficiency. Access the detailed EBITDA figures for JB Chemicals & Pharmaceuticals Ltd in the financials table or ratio section on this page.

JB Chemicals & Pharmaceuticals Ltd DPS

JB Chemicals & Pharmaceuticals Ltd's Dividends Per Share (DPS) signifies the portion of profits distributed to shareholders as dividends. Monitoring DPS is crucial for investors seeking a consistent income from dividends. Our stock analysis page features the DPS data for JB Chemicals & Pharmaceuticals Ltd, allowing investors to track the company's dividend history and payout ratio. Access the detailed DPS information for JB Chemicals & Pharmaceuticals Ltd in the financials table or ratio section on this page.

JB Chemicals & Pharmaceuticals Ltd EPS

Earnings Per Share (EPS) is an important financial metric that measures JB Chemicals & Pharmaceuticals Ltd's profitability on a per-share basis. By analyzing the company's EPS, investors can better understand its earnings performance and growth potential. Our stock analysis page provides detailed EPS information for JB Chemicals & Pharmaceuticals Ltd, enabling investors to assess the company's earnings trends and profitability. Access the comprehensive EPS figures for JB Chemicals & Pharmaceuticals Ltd in the financials table or ratio section on this page to make informed investment decisions.

Read More
X